Gray William Garrett's Form 4 filing
Checkpoint Therapeutics, Inc. (CKPT) · filed Mar 3, 2023
- Accession no.
- 0001104659-23-028602
- Filed
- Mar 3, 2023
- Trade date
- Feb 27-Mar 2, 2023
- Filing delay
- 4 daysLate
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 3 non-derivative transactions. Open-market sales total $26.9K. It was filed 4 days after the trade, past the 2-business-day deadline.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Gray William GarrettCIK 0001692961 | Officer (Chief Financial Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 27, 2023 | Common Stock | SSaleDisposed | −1,914 | $4.66F2 | −$8,919.24 | 47,465 | Direct | |
| Feb 27, 2023 | Common Stock | AGrant or awardAcquired | +7,500 | $0.00 | $0 | 54,965 | Direct | |
| Mar 2, 2023 | Common Stock | SSaleDisposed | −3,591 | $5.00F6 | −$17,955 | 51,374 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
Represents the weighted average price of the shares sold in this transaction. The range of prices for such transaction was $4.65 to $4.69. The reporting person undertakes to provide upon request by the Securities and Exchange Commission staff, the issuer, or a shareholder of the issuer, full information regarding the number of shares sold at each separate price.
Referenced by the price of 1 transaction in Table I.
- F6
Represents the weighted average price of the shares sold in this transaction. The range of prices for such transaction was $5.00 to $5.025. The reporting person undertakes to provide upon request by the Securities and Exchange Commission staff, the issuer, or a shareholder of the issuer, full information regarding the number of shares sold at each separate price.
Referenced by the price of 1 transaction in Table I.